Zinc ion rapidly induces toxic, off-pathway amyloid-β oligomers distinct from amyloid-β derived diffusible ligands in Alzheimer's disease.

about

Zinc ion rapidly induces toxic, off-pathway amyloid-β oligomers distinct from amyloid-β derived diffusible ligands in Alzheimer's disease.

Item

http://www.wikidata.org/entity/Q55222634

description

2018 nî lūn-bûn

@nan

2018年の論文

@ja

2018年学术文章

@wuu

2018年学术文章

@zh

2018年学术文章

@zh-cn

2018年学术文章

@zh-hans

2018年学术文章

@zh-my

2018年学术文章

@zh-sg

2018年學術文章

@yue

2018年學術文章

@zh-hant

name

Zinc ion rapidly induces toxic ...... igands in Alzheimer's disease.

@en

Zinc ion rapidly induces toxic ...... igands in Alzheimer's disease.

@nl

type

Item

label

Zinc ion rapidly induces toxic ...... igands in Alzheimer's disease.

@en

Zinc ion rapidly induces toxic ...... igands in Alzheimer's disease.

@nl

prefLabel

Zinc ion rapidly induces toxic ...... igands in Alzheimer's disease.

@en

Zinc ion rapidly induces toxic ...... igands in Alzheimer's disease.

@nl

P1476

Zinc ion rapidly induces toxic ...... igands in Alzheimer's disease.

@en

P2093

Chun-Yu Chen

http://www.w3.org/2001/XMLSchema#string

Ming-Che Lee

http://www.w3.org/2001/XMLSchema#string

Shing-Jong Huang

http://www.w3.org/2001/XMLSchema#string

Wan-Cheng Yu

http://www.w3.org/2001/XMLSchema#string

Yao-Hsiang Shih

http://www.w3.org/2001/XMLSchema#string

Yun-Ru Chen

http://www.w3.org/2001/XMLSchema#string

Zhong-Hong Guo

http://www.w3.org/2001/XMLSchema#string

P2860

A mutation in APP protects against Alzheimer’s disease and age-related cognitive decline

Cellular prion protein mediates impairment of synaptic plasticity by amyloid-beta oligomers

The coexistence of an equal amount of Alzheimer's amyloid-β 40 and 42 forms structurally stable and toxic oligomers through a distinct pathway

Contribution by synaptic zinc to the gender-disparate plaque formation in human Swedish mutant APP transgenic mice

Soluble oligomers of the amyloid beta-protein impair synaptic plasticity and behavior

The amyloid hypothesis of Alzheimer's disease at 25 years

Structural Correlates of Antibodies Associated with Acute Reversal of Amyloid -related Behavioral Deficits in a Mouse Model of Alzheimer Disease

The amyloid hypothesis of Alzheimer's disease: progress and problems on the road to therapeutics

The antibody aducanumab reduces Aβ plaques in Alzheimer’s disease

Soluble protein oligomers in neurodegeneration: lessons from the Alzheimer's amyloid beta-peptide

P2888

s41598-018-23122-x

P304

4772

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1038/S41598-018-23122-X

http://www.w3.org/2001/XMLSchema#string

P407

English

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Jerry C C Chan

P577

2018-03-19T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1101561586

http://www.w3.org/2001/XMLSchema#string

P698

29555950

http://www.w3.org/2001/XMLSchema#string

P932

5859292

http://www.w3.org/2001/XMLSchema#string